Stay updated on Apitegromab Long-Term Safety & Efficacy in SMA Clinical Trial
Sign up to get notified when there's something new on the Apitegromab Long-Term Safety & Efficacy in SMA Clinical Trial page.

Latest updates to the Apitegromab Long-Term Safety & Efficacy in SMA Clinical Trial page
- Check2 days agoChange DetectedThe web page has been updated to announce a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference6%
- Check9 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference1.0%
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check46 days agoChange DetectedThe web page has updated its version from v2.14.4 to v2.15.0, indicating a significant revision. The phrase 'Here’s how you know' has been removed and replaced with a similar phrase, which does not alter the core content.SummaryDifference1.0%
- Check53 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 20, 2025.SummaryDifference1.0%
- Check96 days agoChange DetectedThe page now includes a new date for the long-term safety and efficacy study of Apitegromab, moving it to February 20, 2025, while a previous date of July 29, 2024, has been removed.SummaryDifference6%
Stay in the know with updates to Apitegromab Long-Term Safety & Efficacy in SMA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Apitegromab Long-Term Safety & Efficacy in SMA Clinical Trial page.